Slide Show | March 2012
Eight Emerging Medical Breakthroughs
Thinkstock
Here are eight medical breakthroughs just over the horizon that could have a profound impact on your life. (Alas, a cure for the common cold is not on the list.) Eight Emerging Medical Breakthroughs
Slide Show
Eight Emerging Medical Breakthroughs
Halting High Blood Pressure
Thinkstock
Researchers have found that some radio frequencies will disable certain nerves in kidneys to significantly lower blood pressure. The treatment involves threading a catheter through an artery in the groin, but doesn't require major surgery.
The treatment, already approved in Europe, should be widely available in the U.S. in about two years. Medtronic is conducting the first U.S. trial. Halting High Blood Pressure
Slide Show
Eight Emerging Medical Breakthroughs
Help for the Heart
Thinkstock
Instead of using a metal stent to open a blocked artery and restore blood flow, Abbott Laboratories is testing a temporary stent that dissolves after two years, leaving behind a healed blood vessel. Abbott is also working on a clip to close a dysfunctional mitral valve. It's delivered by catheter rather than through open heart surgery. Both items are already on the market in Europe.
A replacement heart valve is also coming, from Edwards Life Sciences. Most valve swaps involve open heart surgery with the heart temporarily stopped. This valve would be placed intravenously, with the heart still beating. Help for the Heart
Slide Show
Eight Emerging Medical Breakthroughs
Hope for Diabetics
Thinkstock
The device monitors blood sugar and then administers and adjusts insulin automatically using a computerized insulin pump. One early version, which stops the flow of insulin when glucose levels are too low, is already available overseas and will begin U.S. trials this year.
Among companies involved in development: Medtronic, Dexcom, Insulet Corp. and Johnson & Johnson's Animas Corp. Hope for Diabetics
Slide Show
Eight Emerging Medical Breakthroughs
Helping the Blind to See
A new artificial cornea is also a couple of years away from the U.S. market. KeraMed Inc. is developing an implant that doesn't rely on donor tissue. There's enough tissue to treat only 1% of the 10 million cases of corneal blindness reported worldwide each year. The device, made of a proprietary material, is designed to replace the section of the cornea that focuses light, which is necessary to see.
This version is flexible, so it will require a smaller incision than other implants. That will mean a shorter recovery period and fewer complications.
Further down the road -- five years or so: a drug treatment from Lpath Inc. for macular degeneration, the leading cause of blindness in people over 65. The drug contains antibodies to neutralize molecules that contribute to abnormal growth of blood vessels in the retina. The out-of-control vessels distort central vision. Helping the Blind to See
Slide Show
Eight Emerging Medical Breakthroughs
Taming the Tremors of Parkinson's
Thinkstock
Slide Show
Eight Emerging Medical Breakthroughs
Making Progress Against Cancer
Thinkstock
Vaccines to treat pancreatic and ovarian cancers, melanoma, multiple myeloma and a form of lung cancer are in development but have not yet moved into the FDA approval pipeline.
Also coming: ridaforolimus, from Merck, to treat soft tissue and bone sarcomas; CPI-613, from Cornerstone Pharmaceuticals, to treat pancreatic cancer; cabozantinib, from Exelixis Inc., for prostate, ovarian and liver cancers; and Multikine, from CEL-SCI, for treating advanced head and neck cancers. Making Progress Against Cancer
Slide Show
Eight Emerging Medical Breakthroughs
Easing the Pains of Aging
Thinkstock
One-quarter of those with bone density weakness can't tolerate the most common drugs to treat it, so the alternative will be welcome news for the 10 million people in the U.S., mostly women, with the disease. Easing the Pains of Aging






